MSD (Asia) Limited
At MSD, we aspire to be the premier research-intensive biopharmaceutical company in the world. For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
See below for the Latest MSD (Asia) Limited News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD HK wins big at the HKB Technology Excellence Awards 2022
MSD HK wins big at the HKB Technology Excellence Awards 2022
Its recent innovations have been triggered by the need to address pandemic concerns.
Read Here
Advertise
Sign Up
Commentary
AI, data centres, and the coming energy supercycle in Hong Kong
Reinsurance beyond borders: How Hong Kong can strengthen Asia’s risk-sharing architecture
Hong Kong hospitality insights: Robust investment, tourism expansion, and operational recovery
Hong Kong’s insurance boom is facing a financing test
In the age of AI, creativity is the decisive advantage
Hong Kong cleared stablecoins for take-off. Getting them to work across Asia is the hard part